CNSP
NASDAQ · Pharmaceuticals
Cns Pharmaceuticals Inc
$4.29
+0.01 (+0.23%)
Open$4.25
Previous Close$4.28
Day High$4.36
Day Low$4.25
52W High$12.36
52W Low$1.90
Volume—
Avg Volume21.2K
Market Cap6.87M
P/E Ratio—
EPS$-29.17
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+894.4% upside
Current
$4.29
$4.29
Target
$42.66
$42.66
$27.73
$42.66 avg
$55.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 401.0K | 379.4K | 323.5K |
| Net Income | 137.9K | 129.6K | 106.9K |
| Profit Margin | 34.4% | 34.2% | 33.1% |
| EBITDA | 186.8K | 161.4K | 136.4K |
| Free Cash Flow | 134.0K | 130.1K | 98.1K |
| Rev Growth | +21.3% | -7.8% | +5.5% |
| Debt/Equity | 0.24 | 0.32 | 0.31 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |